Efficacy of sclerotherapy in varicose veins - A prospective, blinded, placebo-controlled study

Dermatologic Surgery

Volumn 30, Issue 5, 2004, Pages 723-728

  Kahle, Birgit ^a   Leng, Katharina ^a   Goldman, Mitchel ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

ARTERIOVENOUS SHUNT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION SCLEROTHERAPY; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMODYNAMICS; HUMAN; LEG VARICOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; VEIN OCCLUSION; VENOARTERIAL FLOW INDEX;

FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM CHLORIDE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 2442706775     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30207.x     Document Type: Article

References (27)

1. Fegan WG. Varicose Veins: Compression Sclerotherapy. London: Heinemann Medical Books, 1967.
2. Sigg K. Varizen, Ulcus Cruris und Thrombose. Berlin/New York: Springer Verlag, 1976.
3. Tournay R. La Sclérose des Varices. Paris: Expansion Scientific Francaise, 1985.
4. Goldman MP. Sclerotherapy: Treatment of Varicose and Teleangiectatic Veins, 2nd ed. St. Louis: Mosby Year Book, 1995.
5. Rabe E, ed. Grundlagen der Phlebologie, 2nd ed. Köln: Viavital, 2000.
6. Staubesand J, Seydewitz V. Zum morpholgischen substrat der venensklerosierung im modellversuch und bei menschlicher varikose. elektronenmikroskopische untersuchung zur theorie der verödungsbehandlung. In: Staubesand J, Schöpf E, eds. Neue Aspekte der Sklerosierungstherapie. Berlin/New York: Springer Verlag, 1990.
7. Rabe E, Pannier-Fischer F, Gerlach H, et al. Sklerosierungsbehandlung der varikose: leitlinie der deutschen gesellschaft für phlebologie. Phlebologie 2003;32:101-6.
8. Baccaglini U, Spreafico G, Castoro C, Sorrentino P. Consensus conference of sclerotherapy or varicose veins of the lower limbs. Phlebology 1997;12:2-16.
9. Kahle B, Hennies F, Hummel S, Petzoldt D. Quantitative venous severity scoring using the venous arterial flow index by duplex sonography. Dermatol Surg 2002;28:1-5.
10. Kahle B, Hummel S, Kirchner P. Korrelationsindex des stromzeit-volume ns in der arteria und vena femoralis communis 'SV-VA-Index' bei verschiedenen stadien der varikosis. Phlebologie 2000;29: 27-31.
11. Kahle B, Hennies F, Bolz S, Feyrer M. Stellenwert des venoarteriellen flow-index (VAFI) in der phlebologischen diagnositk (reliabilität und validität)-ergebnisse der forschungsförderung der Deutschen gesellschaft für phlebologie. Phlebologie 2003;32:A7.
12. Kahle B, Hennies F, Bolz S, Pritsch M. The reproducibility of the ratio in the common femoral vein and artery for quantification of the severity of venous insufficiency. VASA 2003;32:199-203.
13. Hennies F, Kahle B. Bleibt der korrelationsindex aus venösem und arteriellem stromzeitvolume n (VAFI) über einen längeren messzeitraum stabil? Phlebologie 2001;30:53-9.
14. Kahle B, Hummel S, Kirchner P, Hennies F. Quantification of the effect of venous surgery on venous hemodynamics using the venoarterial flow index (VAFI) by duplex sonography. Int Angiol 2001; 20(1 Suppl 1):23.
15. Bock J. Bestimmung des Stichprobenumfangs. München/Wien: Oldenbourg, 1998.
16. Tisi PV, Beverley CA. Injection sclerotherapy for varicose veins (Cochrane review). In: The Cochrane Library, Issue 1. Chichester: Wiley, 2004.
17. Goldman MP. Treatment of varicose and teleangiectatic leg veins: double-blind prospective comparative trial between aethoxysxclerol and sotradecol. Dermatol Surg 2002;28:46-51.
18. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (aethoxysclerol) study: results at 2 years. Dermatol Surg 1995;21: 334-6.
19. Prescott RA. A comparative study of two sclerosing agents in the treatment of teleangiectasias. In: Raymond-Martimbeau P, Prescott RA, Zummo M, eds. Phlebology 92, Vol. 2. Paris: Libbey Eurotext, 1992:803-4.
20. Stanley PRW, Bickerton DR, Campbell WB. Injection sclerotherapy for varicose veins - a comparison of materials for applying local compression. Phlebology 1991;6:37-9.
21. Reddy P, Wickers J, Terry T, et al. What is the correct period of compression following sclerotherapy? Phlebology 1986;1:217-20.
22. Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25: 105-8.
23. McDonagh B. Comments on the use of post-sclerotherapy compression. Dermatol Surg 1999;25:519-21.
24. Massay RA. Regarding the use of compression stockings after sclerotherapy. Dermatol Surg 1999;25:517.
25. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 1996;34:523-8.
26. Kahle B, Hummel S, Kirchner P. Quantifizierung des effektes von varizenoperationen auf die venöse hämodynamik mittels des venoarteriellen flow-index (VAFI). Phlebologie 2001;30:1-6.
27. Kahle B. Quantification of the Hemodynamic Improvement According Compression Stockings Using Duplex Sonography. Abstract, UIP World Congress Chapter Meeting. San Diego, CA, 2003 Aug: 27-31.